What’s going on with the market this week? Well, the accepted narrative keeps shifting — first we had trade war panic as Trump announced new tariffs last week, then celebration as those tariffs were delayed to ‘save Christmas’, and the market is overly obsessed with the high-level game of chicken being played by Trump and […]
Articles
I covered a “powdered plasma” ad from Michael Robinson just yesterday, but it turns out the he’s also flogging “cryogenic blood” separately, in different ads for his same Nova-X Report newsletter, so I thought I better follow up to get rid of any confusion. The Thinkolator concluded that yesterday’s ad, teasing a Pennsylvania company, was […]
[ed note: Michael Jorrin is longtime medical writer who has been sharing his thoughts with our readers as “Doc Gumshoe” for several years (he’s not a doctor, I gave him the name). He generally covers medical and health news and sometimes health promotions and hype, but he rarely opines about investments or specific stocks. All of his past […]
The folks at Money Map/Money Morning have really taken the “most aggressive advertisers” mantle from the other Agora affiliates of late — we can pretty much count on a new promotional campaign from this publisher becoming the “most asked about” pitch by our readers almost instantly, whether it’s Michael Robinson or Keith Fitz-Gerald or Dr. […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Travis, CERS 3Q call had no surprises, despite analysts attempts to pull teeth. Management refuses to be promotional, ...
My feelings and results exactly, ONLY worse. Obviously the word integrity isn't in his vast vocabulary !...
an additional observation re CERS: having listened to each conf call for the last several years, this management team f...
Snake Oil Salesmen 150 years ago were dirty,unshaven foul mouths with a dirty cigar hanging from their lips.....I hardly...
that teaser's description of CERS' business is weird, and it would be worth going over the last cc transcript to get a c...
$CERS starting to make sales: Cerus (CERS) And Bonfils Blood Center Enter Into Agreement For The Use Of INTERCEPT Plate...
Some positive up action today in Cerus ($CERS). Have we discussed this one here? CERS has a method of cleansing plat...